Gateway 2011: MPI Research - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: MPI Research


Your online Gateway to MPI Research in 2011!

MPI Research
Corporate Headquarters
54943 North Main Street
Mattawan, MI 49071 USA

Phone: +1.269.668.3336
Fax: +1.269.668.4151
www.mpiresearch.com

Don't miss MPI Research at AAPS, October 23-27 in Washington, DC!


About MPI Research


MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, agricultural, environmental, and chemical industries. Specialized analytical testing services are available in Mattawan as well as at the State College, PA, facility. Scientific knowledge and experience, quick turnaround, and dedication to strong and enduring customer relationships characterize MPI Research as a high-performance, high-quality organization committed to bringing safer and more effective products to the world. Learn more about how we can exceed your expectations at www.mpiresearch.com.

Visit our Booth: # 305
We look forward to greeting you at AAPS in booth 305 and discussing how we can help move your drug development projects forward. Also be sure to attend the following presentations:

  • Poster Title:  Validation of a Bioanalytical ICP-MS Method for Quantification of Potassium in Human Urine
  • Symposium Session Title: Formulation Quality Control Issues In Nonclinical Dosing (#171) featuring Monica Whitmire’s
    Symposium Presentation:  Is it a Solution or a Suspension? Repercussions for NCDFA

 

New Products and Releases

Derrington Named President and COO

Development of a Ligand-Binding Assay
Analytical and Bioanalytical Options for the Preclinical Evaluation of Protein Biologics Using LC-MS/MS for the Bioanalysis of Proteins
Current Trends in Developmental and Reproductive Toxicology Symposium Options for Bioanalysis at MPI Research— Immunoassay and LC-MS/MS Techniques

Leading the Way with the SEND Initiative

Gyros Gyrolab™ offers Analytical Testing Advantages

 

 



 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here